Close
  Indian J Med Microbiol
 

Table 4 :Initial empiric therapy for HAP/VAP in patients with late-onset disease or risk factors for MDR pathogens and all disease severity (adapted from ATS guidelines; 2005)

Table 4 :Initial empiric therapy for HAP/VAP in patients with late-onset disease or risk factors for MDR pathogens and all disease severity (adapted from ATS guidelines; 2005)